For research use only. Not for therapeutic Use.
Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab has potential application in renal transplant[1][2].
| Catalog Number | I041613 |
| CAS Number | 2098280-42-1 |
| Purity | ≥95% |
| Reference | [1]. Tempest R, et al. The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment. Cancers (Basel). 2021 Jun 3;13(11):2788. [2]. Prat-Duran J, et al. Transglutaminase 2 as a novel target in chronic kidney disease – Methods, mechanisms and pharmacological inhibition. Pharmacol Ther. 2021 Jun;222:107787. |
